RE: Its all about the timing!24 Jan 2019 16:23
timing and the right product.
This is why its a persuasive investment case:::
Iclaprim, Motif's new drug, attacks folate production, which is a novel way of killing bacteria.
This means there will be no resistance to Iclaprim as opposed to other antibiotics. - [Seeking Alpha]